Ultragenyx
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $139,494 | $147,026 | $108,833 | $127,392 |
Gross Profit | 118,473 | 116,884 | 82,455 | 115,341 |
EBITDA | -108,744 | -105,918 | -145,537 | -101,346 |
EBIT | -117,501 | -114,780 | -154,382 | -109,564 |
Net Income | -133,516 | -131,598 | -170,684 | -123,190 |
Net Change In Cash | 139,494 | 147,026 | 108,833 | 127,392 |
Free Cash Flow | -68,612 | -81,472 | -203,938 | -85,504 |
Cash | 156,795 | 486,865 | 118,554 | 213,584 |
Basic Shares | 95,493 | 86,580 | 84,286 | 81,118 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $434,249 | $363,329 | $351,406 | $271,030 |
Gross Profit | 389,040 | 335,009 | 335,398 | 264,901 |
EBITDA | -516,454 | -640,510 | -410,320 | -139,807 |
EBIT | -542,460 | -658,710 | -423,559 | -152,068 |
Net Income | -606,639 | -707,421 | -454,025 | -186,566 |
Net Change In Cash | 434,249 | 363,329 | 351,406 | 271,030 |
Cost of Revenue | -170,909 | -415,515 | 288,931 | |
Free Cash Flow | -521,573 | -526,588 | -411,788 | -176,125 |
Cash | 213,584 | 132,944 | 307,584 | 713,526 |
Basic Shares | 73,543 | 69,914 | 67,795 | 60,845 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.40 |
2024-06-30 | -$1.52 |
2024-03-31 | -$2.03 |
2023-12-31 | -$1.52 |
